Annual Revenue
$6.81 M
-$27.41 M-80.09%
31 December 2023
Summary:
Co-Diagnostics annual revenue is currently $6.81 million, with the most recent change of -$27.41 million (-80.09%) on 31 December 2023. During the last 3 years, it has fallen by -$67.74 million (-90.86%). CODX annual revenue is now -93.04% below its all-time high of $97.89 million, reached on 31 December 2021.CODX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$641.10 K
-$2.02 M-75.87%
30 September 2024
Summary:
Co-Diagnostics quarterly revenue is currently $641.10 thousand, with the most recent change of -$2.02 million (-75.87%) on 30 September 2024. Over the past year, it has dropped by -$1.82 million (-73.91%). CODX quarterly revenue is now -97.87% below its all-time high of $30.10 million, reached on 30 September 2021.CODX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$7.11 M
-$1.82 M-20.35%
30 September 2024
Summary:
Co-Diagnostics TTM revenue is currently $7.11 million, with the most recent change of -$1.82 million (-20.35%) on 30 September 2024. Over the past year, it has increased by +$2.45 million (+52.54%). CODX TTM revenue is now -93.21% below its all-time high of $104.63 million, reached on 30 September 2021.CODX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CODX Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -80.1% | -73.9% | +52.5% |
| 3 y3 years | -90.9% | -97.9% | -93.2% |
| 5 y5 years | +10000.0% | +1448.5% | +5963.0% |
CODX Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -93.0% | at low | -97.9% | +224.1% | -93.2% | +52.5% |
| 5 y | 5 years | -93.0% | >+9999.0% | -97.9% | +1448.5% | -93.2% | +5963.0% |
| alltime | all time | -93.0% | >+9999.0% | -97.9% | >+9999.0% | -93.2% | >+9999.0% |
Co-Diagnostics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $641.10 K(-75.9%) | $7.11 M(-20.4%) |
| June 2024 | - | $2.66 M(+951.4%) | $8.92 M(+38.0%) |
| Mar 2024 | - | $252.70 K(-92.9%) | $6.46 M(-5.1%) |
| Dec 2023 | $6.81 M(-80.1%) | $3.56 M(+44.7%) | $6.81 M(+46.2%) |
| Sept 2023 | - | $2.46 M(+1142.2%) | $4.66 M(-36.1%) |
| June 2023 | - | $197.80 K(-67.1%) | $7.30 M(-39.8%) |
| Mar 2023 | - | $602.00 K(-57.0%) | $12.12 M(-64.6%) |
| Dec 2022 | $34.22 M(-65.0%) | $1.40 M(-72.5%) | $34.22 M(-35.7%) |
| Sept 2022 | - | $5.09 M(+1.4%) | $53.22 M(-32.0%) |
| June 2022 | - | $5.02 M(-77.9%) | $78.22 M(-22.2%) |
| Mar 2022 | - | $22.70 M(+11.3%) | $100.56 M(+2.7%) |
| Dec 2021 | $97.89 M(+31.3%) | $20.40 M(-32.2%) | $97.89 M(-6.4%) |
| Sept 2021 | - | $30.10 M(+10.0%) | $104.63 M(+8.6%) |
| June 2021 | - | $27.36 M(+36.6%) | $96.35 M(+3.6%) |
| Mar 2021 | - | $20.02 M(-26.2%) | $93.03 M(+24.8%) |
| Dec 2020 | $74.55 M | $27.15 M(+24.4%) | $74.55 M(+56.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $21.82 M(-9.2%) | $47.52 M(+84.6%) |
| June 2020 | - | $24.04 M(+1452.5%) | $25.74 M(+1362.3%) |
| Mar 2020 | - | $1.55 M(+1325.9%) | $1.76 M(+718.7%) |
| Dec 2019 | $215.00 K(+438.8%) | $108.60 K(+162.3%) | $215.00 K(+83.4%) |
| Sept 2019 | - | $41.40 K(-32.8%) | $117.20 K(+37.1%) |
| June 2019 | - | $61.60 K(+1711.8%) | $85.50 K(+154.5%) |
| Mar 2019 | - | $3400.00(-68.5%) | $33.60 K(-15.8%) |
| Dec 2018 | $39.90 K(+418.2%) | $10.80 K(+11.3%) | $39.90 K(+25.9%) |
| Sept 2018 | - | $9700.00(0.0%) | $31.70 K(+28.9%) |
| June 2018 | - | $9700.00(0.0%) | $24.60 K(+41.4%) |
| Mar 2018 | - | $9700.00(+273.1%) | $17.40 K(+126.0%) |
| Dec 2017 | $7700.00(-23.0%) | $2600.00(0.0%) | $7700.00(+51.0%) |
| Sept 2017 | - | $2600.00(+4.0%) | $5100.00(+104.0%) |
| June 2017 | - | $2500.00(-75.0%) | $2500.00(-75.0%) |
| Mar 2016 | - | $10.00 K | $10.00 K |
| Dec 2015 | $10.00 K | - | - |
FAQ
- What is Co-Diagnostics annual revenue?
- What is the all time high annual revenue for Co-Diagnostics?
- What is Co-Diagnostics annual revenue year-on-year change?
- What is Co-Diagnostics quarterly revenue?
- What is the all time high quarterly revenue for Co-Diagnostics?
- What is Co-Diagnostics quarterly revenue year-on-year change?
- What is Co-Diagnostics TTM revenue?
- What is the all time high TTM revenue for Co-Diagnostics?
- What is Co-Diagnostics TTM revenue year-on-year change?
What is Co-Diagnostics annual revenue?
The current annual revenue of CODX is $6.81 M
What is the all time high annual revenue for Co-Diagnostics?
Co-Diagnostics all-time high annual revenue is $97.89 M
What is Co-Diagnostics annual revenue year-on-year change?
Over the past year, CODX annual revenue has changed by -$27.41 M (-80.09%)
What is Co-Diagnostics quarterly revenue?
The current quarterly revenue of CODX is $641.10 K
What is the all time high quarterly revenue for Co-Diagnostics?
Co-Diagnostics all-time high quarterly revenue is $30.10 M
What is Co-Diagnostics quarterly revenue year-on-year change?
Over the past year, CODX quarterly revenue has changed by -$1.82 M (-73.91%)
What is Co-Diagnostics TTM revenue?
The current TTM revenue of CODX is $7.11 M
What is the all time high TTM revenue for Co-Diagnostics?
Co-Diagnostics all-time high TTM revenue is $104.63 M
What is Co-Diagnostics TTM revenue year-on-year change?
Over the past year, CODX TTM revenue has changed by +$2.45 M (+52.54%)